查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1403403

到 2030 年防揭包裝市場預測：按產品、材料、應用、最終用戶和地區進行全球分析

Tamper Evident Packaging Market Forecasts to 2030 - Global Analysis By Product, Material, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2023 年全球防揭包裝市場規模為 17.8 億美元，預計在預測期內將以 8.2% 的複合年成長率成長，到 2030 年達到 38.4 億美元。

防揭包裝透過提供可見的篡改和詐欺徵兆來確保藥品和醫療產品的完整性。它們在確保患者安全和維持藥物有效性方面發揮關鍵作用。透過利用密封件、標籤和封口等旨在防止破損或在打開時顯示篡改證據的功能，防防揭包裝可以為消費者和醫療保健專業人員提供信心。

印度包裝研究所(IIP)的數據顯示，過去十年印度的包裝消費量激增200%，從2010年的4.3公斤人均年消費量(pppa)增加到2020年的8.6公斤pppa。

成長動力：仿冒品增加

隨著藥品和醫療產品的假冒現像不斷增加，防揭包裝為消費者和醫療保健專業人員提供了重要的安全層，以確保產品的完整性。防篡改功能有助於防止在產品分發和儲存過程中詐欺的存取和篡改，從而保護患者的健康和福祉。因此，醫療保健產業擴大採用防揭包裝解決方案來應對日益成長的假藥威脅。

成長抑制因素：相容性問題

藥品種類繁多，需要適合其需求的包裝解決方案。實現防揭功能與不同包裝材料、尺寸和形狀之間的兼容性是一項挑戰。障礙在於平衡有效的詐欺篡改和適應不同的產品規格。這種複雜性增加了製造成本並阻礙了與現有藥物製造流程的無縫整合。

機會：人們對產品安全的認知與興趣不斷增強

隨著消費者對藥品和醫療產品的真實性和完整性越來越警惕，防揭包裝已成為一個重要的解決方案。透過提供干擾或篡改的明顯證據，建立信任並確保消費者產品的完整性。這種對安全性的日益關注與醫療保健行業維持最高標準的承諾是一致的，而防揭包裝滿足並支持了對安全可靠的醫療保健產品不斷成長的需求。這是一個值得利用的重要策略。

威脅：成本

實施防揭包裝解決方案通常需要在材料、技術和遵守嚴格法規方面產生額外成本。對創新密封件、全像標籤和其他安全措施的需求增加了製造成本。醫療保健行業的預算普及可能會阻礙相關人員的採用並限制其獲得防揭包裝。此外，實施防篡改技術需要研發投資才能領先造假者，這進一步阻礙了市場擴張。

COVID-19 的影響

COVID-19 的疫情對市場產生了重大影響。人們對衛生和安全意識的提高增加了對藥品和醫療包裝中防篡改解決方案的需求，以確保產品的完整性。這場大流行加速了防揭包裝的採用，以防止污染和詐欺的取得醫療用品。這導致了防篡改技術的投資和創新激增，重塑了醫療保健包裝形勢，以解決行業中日益成長的安全問題。

處方藥市場預計將在預測期內成為最大的市場

處方藥領域預計將出現良好的成長。透過採用各種密封件和特徵，該包裝確保了藥品的完整性。透過提供篡改或篡改企圖的明顯證據，防揭包裝使消費者和醫療保健專業人員對藥品的真實性和安全性充滿信心。這種預防措施有助於降低污染、替代和詐欺取得處方藥的風險，加強監管合規性，並提高病患對藥品供應鏈的信任。

預計製藥領域在預測期內複合年成長率最高

預計製藥公司細分市場在預測期內將以最高的複合年成長率成長。防揭包裝在製藥公司確保藥品的安全性和完整性方面發揮著重要作用。這包括整合可揭示任何干擾並提供明顯篡改證據的功能。這對於防止污染、偽造和詐欺獲取藥品至關重要。它還透過確保藥品的真實性和安全性來保護消費者，並促進整體公共衛生和監管合規性。

比最大的地區

由於對假藥和醫療產品的擔憂日益增加，預計亞太地區在預測期內將佔據最大的市場佔有率。印度和中國等國家特別採用這些包裝技術，以確保整個供應鏈中藥品和醫療設備的完整性。 Amcor Limited、Mondi Group、DuPont 和 Sonoco 等主要公司都在印度開展業務。此外，嚴格的法規、對病人安全的日益關注以及醫療保健相關人員意識的提高，導致對防揭包裝解決方案的需求不斷成長。

複合年成長率最高的地區

由於嚴格的法規和對病人安全的日益重視，預計歐洲在預測期內將經歷最高的複合年成長率。隨著歐洲不斷加強醫療保健標準，解決與產品安全和真實性相關的關鍵問題，該地區的防揭包裝市場持續擴大。歐洲的主要企業包括 Essentra Plc、Clondalkin Group 和 Sappi Limited。主要企業正在利用先進技術進行創新，提供防篡改解決方案，將歐洲定位為市場的關鍵地區。

免費客製化服務：

訂閱此報告的客戶可以利用以下免費自訂選項之一：

  • 公司簡介
    • 其他市場公司的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 應用分析
  • 最終用戶分析
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 公司之間的競爭關係

第5章全球防揭包裝市場：依產品

  • 收縮套管
  • 感應密封
  • 薄膜包裝紙
  • 泡殼/帶狀包裝
  • 氣泡包
  • 其他產品

第6章全球防揭包裝市場：依材料分類

  • 塑膠
  • 玻璃
  • 紙
  • 金屬
  • 其他材料

第7章全球防揭包裝市場：依應用分類

  • 成藥(OTC)
  • 處方藥
  • 生技藥品
  • 醫療設備
  • 其他用途

第8章全球防揭包裝市場：依最終用戶分類

  • 製藥公司
  • 醫療設備製造商
  • 醫院和診所
  • 研究機構
  • 其他最終用戶

第9章全球防揭包裝市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第10章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第11章 公司簡介

  • Schreiner Group
  • Avery Dennison Corporation
  • CCL Industries Inc
  • Essentra PLC
  • 3M Company
  • SCHOTT AG
  • Amcor Plc
  • DuPont de Nemours Inc
  • Systech International
  • Covectra
  • Ampac Holding LLC
  • Baker & McKenzie LLP
  • Dynacorp
  • Enercon Corporation
  • Berry Global Healthcare
  • Traco Manufacturing Inc
  • Interpack Limited
  • Seal King Europe
Product Code: SMRC24628

According to Stratistics MRC, the Global Tamper Evident Packaging Market is accounted for $1.78 billion in 2023 and is expected to reach $3.84 billion by 2030 growing at a CAGR of 8.2% during the forecast period. Tamper-evident packaging ensures the integrity of pharmaceuticals and medical products by providing visible signs of interference or tampering. It plays a critical role in safeguarding patient safety and maintaining the efficacy of medications. Utilizing features like seals, labels, and closures that are designed to break or show evidence of tampering upon opening, tamper-evident packaging instills confidence in consumers and healthcare professionals.

According to the Indian Institute of Packaging (IIP), packaging consumption in India has surged by 200% over the last decade, from 4.3 kilograms per person per annum (pppa) in FY10 to 8.6 kg pppa in FY20.

Market Dynamics:

Driver:

Rising incidents of counterfeiting

With the rise in counterfeit drugs and medical products, tamper-evident packaging provides a crucial layer of security, assuring consumers and healthcare professionals of the product's integrity. The tamper-resistant features help prevent unauthorized access and tampering during the product's distribution and storage, safeguarding the health and well-being of patients. As a result, the healthcare industry is increasingly embracing tamper-evident packaging solutions to combat the growing threat of counterfeit pharmaceuticals.

Restraint:

Compatibility issues

The diverse range of pharmaceutical products often requires tailored packaging solutions. Achieving compatibility between tamper-evident features and various packaging materials, sizes, and forms can be challenging. Striking a balance between effective tamper resistances and accommodating different product specifications becomes a hurdle. This complexity can result in increased production costs and hinder seamless integration into existing pharmaceutical manufacturing processes.

Opportunity:

Growing awareness & concern for product safety

As consumers become increasingly vigilant about the authenticity and integrity of pharmaceuticals and medical products, tamper-evident packaging serves as a crucial solution. It helps build trust by providing visible evidence of any interference or tampering, assuring consumers of product integrity. This heightened focus on safety aligns with the healthcare sector's commitment to maintaining the highest standards, making tamper-evident packaging a key strategy to address and capitalize on the increasing demand for secure and trustworthy healthcare products.

Threat:

Cost considerations

Implementing tamper-evident packaging solutions often involves additional expenses for materials, technology, and compliance with stringent regulations. The need for innovative seals, holographic labels, or other security measures increases production costs. The healthcare industry's budget constraints may deter widespread adoption, limiting access to tamper-proof packaging for some stakeholders. Additionally, implementing tamper-evident technologies requires investment in research and development to stay ahead of counterfeiters which further impedes the market expansion.

COVID-19 Impact

The COVID-19 pandemic has significantly impacted the market. With heightened awareness of hygiene and safety, there is an increased demand for tamper-evident solutions in pharmaceutical and medical packaging to ensure product integrity. The pandemic has accelerated the adoption of tamper-proof packaging to prevent contamination and unauthorized access to medical supplies. This has led to a surge in investments and innovations in tamper-evident technologies, reshaping the healthcare packaging landscape to meet the evolving safety concerns in the industry.

The prescription drugs segment is expected to be the largest during the forecast period

The prescription drugs segment is estimated to have a lucrative growth. Employing various seals and features, this packaging ensures the integrity of pharmaceutical products. By visibly indicating any interference or opening attempts, tamper-evident packaging provides consumers and healthcare professionals with confidence in the authenticity and safety of the medication. This preventive measure helps mitigate the risk of contamination, substitution, or unauthorized access to prescription drugs, reinforcing regulatory compliance and promoting patient trust in the pharmaceutical supply chain.

The pharmaceutical companies segment is expected to have the highest CAGR during the forecast period

The pharmaceutical companies segment is anticipated to witness the highest CAGR growth during the forecast period. Tamper-evident packaging plays a crucial role in pharmaceutical companies to ensure the safety and integrity of medical products. It involves incorporating features that reveal any interference, providing visible evidence of tampering. This is paramount for preventing contamination, counterfeiting, and unauthorized access to medications. It also protects consumers by guaranteeing the authenticity and safety of medications, promoting overall public health and regulatory compliance.

Region with largest share:

Asia Pacific is projected to hold the largest market share during the forecast period owing to the escalating concerns about counterfeit drugs and medical products. Countries like India and China are particularly embracing these packaging technologies to ensure the integrity of pharmaceuticals and medical devices throughout the supply chain. It has the presence of major companies namely Amcor Limited, Mondi Group, DuPont and Sonoco. Further, stringent regulations, a growing focus on patient safety, and increasing awareness among healthcare stakeholders contribute to the expanding demand for tamper-evident packaging solutions.

Region with highest CAGR:

Europe is projected to have the highest CAGR over the forecast period, owing to stringent regulations and the growing emphasis on patient safety. As Europe remains committed to enhancing healthcare standards, the Tamper-Evident Packaging market in the region continues to witness expansion, addressing critical concerns related to product safety and authenticity. Europe is home to several key players including Essentra Plc, Clondalkin Group and Sappi Limited. Key players are innovating with advanced technologies to offer tamper-proof solutions, positioning Europe as a pivotal region in the market.

Key players in the market:

Some of the key players profiled in the Tamper Evident Packaging Market include Schreiner Group, Avery Dennison Corporation, CCL Industries Inc, Essentra PLC, 3M Company, SCHOTT AG, Amcor Plc, DuPont de Nemours Inc, Systech International, Covectra, Ampac Holding LLC, Baker & McKenzie LLP, Dynacorp, Enercon Corporation, Berry Global Healthcare, Traco Manufacturing Inc, Interpack Limited and Seal King Europe.

Key Developments:

In April 2023, Schreiner MediPharm has launched a new product for counterfeit and tampering protection in the healthcare industry. The product utilizes void labels, which reveals covert messages upon peeling and makes it difficult for counterfeiters to reuse the original packaging.

In February 2023, Berry Global Healthcare is introducing a comprehensive bundle solution to help customers capitalise on the increasing demand for child-resistant (CRC) and tamper-evident (TE) packaging for the pharmaceutical and herbal market for syrup and liquid medicines. The new Berry Healthcare bundle features seven ranges of 28mm neck PET bottles in sizes from 20ml to 1,000ml and a variety of designs, with eight accompanying closures that incorporate tamper-evident and child-resistant features.

Products Covered:

  • Shrink Sleeves
  • Induction Seal
  • Film Wrappers
  • Blister/Strip Packs
  • Bubble Packs
  • Other Products

Materials Covered:

  • Plastic
  • Glass
  • Paper
  • Metal
  • Other Materials

Applications Covered:

  • Over-The-Counter (OTC) Drugs
  • Prescription Drugs
  • Biologics
  • Medical Devices
  • Other Applications

End Users Covered:

  • Pharmaceutical Companies
  • Medical Device Manufacturers
  • Hospitals & Clinics
  • Research Institutions
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Tamper Evident Packaging Market, By Product

  • 5.1 Introduction
  • 5.2 Shrink Sleeves
  • 5.3 Induction Seal
  • 5.4 Film Wrappers
  • 5.5 Blister/Strip Packs
  • 5.6 Bubble Packs
  • 5.7 Other Products

6 Global Tamper Evident Packaging Market, By Material

  • 6.1 Introduction
  • 6.2 Plastic
  • 6.3 Glass
  • 6.4 Paper
  • 6.5 Metal
  • 6.6 Other Materials

7 Global Tamper Evident Packaging Market, By Application

  • 7.1 Introduction
  • 7.2 Over-The-Counter (OTC) Drugs
  • 7.3 Prescription Drugs
  • 7.4 Biologics
  • 7.5 Medical Devices
  • 7.6 Other Applications

8 Global Tamper Evident Packaging Market, By End User

  • 8.1 Introduction
  • 8.2 Pharmaceutical Companies
  • 8.3 Medical Device Manufacturers
  • 8.4 Hospitals & Clinics
  • 8.5 Research Institutions
  • 8.6 Other End Users

9 Global Tamper Evident Packaging Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Schreiner Group
  • 11.2 Avery Dennison Corporation
  • 11.3 CCL Industries Inc
  • 11.4 Essentra PLC
  • 11.5 3M Company
  • 11.6 SCHOTT AG
  • 11.7 Amcor Plc
  • 11.8 DuPont de Nemours Inc
  • 11.9 Systech International
  • 11.10 Covectra
  • 11.11 Ampac Holding LLC
  • 11.12 Baker & McKenzie LLP
  • 11.13 Dynacorp
  • 11.14 Enercon Corporation
  • 11.15 Berry Global Healthcare
  • 11.16 Traco Manufacturing Inc
  • 11.17 Interpack Limited
  • 11.18 Seal King Europe

List of Tables

  • Table 1 Global Tamper Evident Packaging Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Tamper Evident Packaging Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Tamper Evident Packaging Market Outlook, By Shrink Sleeves (2021-2030) ($MN)
  • Table 4 Global Tamper Evident Packaging Market Outlook, By Induction Seal (2021-2030) ($MN)
  • Table 5 Global Tamper Evident Packaging Market Outlook, By Film Wrappers (2021-2030) ($MN)
  • Table 6 Global Tamper Evident Packaging Market Outlook, By Blister/Strip Packs (2021-2030) ($MN)
  • Table 7 Global Tamper Evident Packaging Market Outlook, By Bubble Packs (2021-2030) ($MN)
  • Table 8 Global Tamper Evident Packaging Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 9 Global Tamper Evident Packaging Market Outlook, By Material (2021-2030) ($MN)
  • Table 10 Global Tamper Evident Packaging Market Outlook, By Plastic (2021-2030) ($MN)
  • Table 11 Global Tamper Evident Packaging Market Outlook, By Glass (2021-2030) ($MN)
  • Table 12 Global Tamper Evident Packaging Market Outlook, By Paper (2021-2030) ($MN)
  • Table 13 Global Tamper Evident Packaging Market Outlook, By Metal (2021-2030) ($MN)
  • Table 14 Global Tamper Evident Packaging Market Outlook, By Other Materials (2021-2030) ($MN)
  • Table 15 Global Tamper Evident Packaging Market Outlook, By Application (2021-2030) ($MN)
  • Table 16 Global Tamper Evident Packaging Market Outlook, By Over-The-Counter (OTC) Drugs (2021-2030) ($MN)
  • Table 17 Global Tamper Evident Packaging Market Outlook, By Prescription Drugs (2021-2030) ($MN)
  • Table 18 Global Tamper Evident Packaging Market Outlook, By Biologics (2021-2030) ($MN)
  • Table 19 Global Tamper Evident Packaging Market Outlook, By Medical Devices (2021-2030) ($MN)
  • Table 20 Global Tamper Evident Packaging Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 21 Global Tamper Evident Packaging Market Outlook, By End User (2021-2030) ($MN)
  • Table 22 Global Tamper Evident Packaging Market Outlook, By Pharmaceutical Companies (2021-2030) ($MN)
  • Table 23 Global Tamper Evident Packaging Market Outlook, By Medical Device Manufacturers (2021-2030) ($MN)
  • Table 24 Global Tamper Evident Packaging Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
  • Table 25 Global Tamper Evident Packaging Market Outlook, By Research Institutions (2021-2030) ($MN)
  • Table 26 Global Tamper Evident Packaging Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.